Vincristine and venoocclusive liver disease Patient Reports February 12, 2012

Vincristine Side Effects Report #4786704-X
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: 1.5 MG /M2 PER CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient recovered.

Vincristine Side Effects Report #4786731-2
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient, child 5 years of age, was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: 1.5 MG/M2 PER_CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient died.

Vincristine Side Effects Report #4786708-7
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient, child 4 years of age, was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: 1.5 MG/M2 PER_CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.

Vincristine Side Effects Report #4786727-0
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient, child 4 years of age, was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: 1.5 MG/M2 PER_CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient died.


Vincristine Side Effects Report #4786725-7
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient, child 3 years of age, was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: 1.5 MG/M2 PER_CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient recovered.

Vincristine Side Effects Report #4786723-3
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient, 17 years of age, was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: 1.5 MG/M2 PER_CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient recovered.

Vincristine Side Effects Report #4786707-5
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient, child 12 years of age, was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: 1.5 MG/M2 PER CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient recovered.

Vincristine Side Effects Report #4786217-5
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient recovered.

Vincristine Side Effects Report #4786703-8
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: 1.5 MG/M2 PER CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient recovered.


Vincristine Side Effects Report #4786705-1
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: 1.5 MG/M2 PER CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient recovered.

Vincristine Side Effects Report #4786706-3
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: 1.5 MG/M2 PER CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient died.

Vincristine Side Effects Report #4786711-7
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: 1.5 MG/M2 PER CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient recovered.

Vincristine Side Effects Report #4786712-9
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: 1.5 MG/M2 PER CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient recovered.

Vincristine Side Effects Report #4786728-2
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: 1.5 MG/M2 PER_CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient died.


Vincristine Side Effects Report #4786730-0
Vincristine side effect was reported by a Physician from UNITED STATES on Sept 15, 2005. Female patient was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Vincristine dosage: 1.5 MG/M2 PER_CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient recovered.

Vincristine Side Effects Report #4716388-8
Vincristine side effect was reported by a Consumer or non-health professional from ITALY on July 04, 2005. Female patient, 14 years of age, was treated with Vincristine. After drug was administered, patient experienced the following side effects: ascites, hepatic function abnormal, hepatic pain, hepatomegaly, hepatotoxicity, ileus paralytic, mucosal inflammation, venoocclusive liver disease, weight increased. Vincristine dosage: 1.5 MG/M2 IV. During the same period patient was treated with DOXORUBICIN, IFOSFAMIDE, DACTINOMYCIN, MERCAPTOETHANE. Patient recovered.